Prelude Capital Management’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,067
| Closed | -$26.5K | – | 976 |
|
|
2025
Q1 | $26.5K | Buy |
+13,067
| New | +$26.5K | ﹤0.01% | 1031 |
|
|
2024
Q4 | – | Sell |
-37,727
| Closed | -$264K | – | 1056 |
|
|
2024
Q3 | $264K | Buy |
+37,727
| New | +$264K | 0.02% | 841 |
|
|
2024
Q2 | – | Sell |
-13,000
| Closed | -$93K | – | 1093 |
|
|
2024
Q1 | $93K | Buy |
+13,000
| New | +$93K | ﹤0.01% | 1096 |
|